V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10390590 | 10040754 | 1.7 | 85.7 | Palliative (P) | 2017-10-09 | 2017-10-16 | Temozolomide 150mg/m2 | 02 | N | TEMOZOLOMIDE | 100075916 |
| 10390613 | 10040755 | 1.74 | 53.7 | Adjuvant (A) | 2017-11-22 | 2017-11-26 | Avelumab | 02 | N | AVELUMAB | 101441547 |
| 10390634 | 10040756 | 0 | null | Curative (C) | 2022-03-18 | 2022-03-18 | FEC + DOCETAXEL | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100489575 |
| 10390718 | 10040757 | 1.75 | 74.7 | Curative (C) | 2018-01-11 | 2018-02-15 | CHOP R - 21 days | 02 | null | CHOP R | 101564980 |
| 10390747 | 10040758 | 1.72 | 61 | null | 2018-11-06 | 2018-11-08 | Sunitinib | 02 | null | VENETOCLAX | 101002853 |
| 10390829 | 10040759 | 1.6 | 64.4 | Adjuvant (A) | 2016-11-16 | 2016-11-23 | Avelumab | 02 | N | AVELUMAB | 101584587 |
| 10391100 | 10040761 | null | null | null | 2018-02-19 | 2018-02-20 | CARBOPLATIN + VINORELBINE | 02 | N | CARBOPLATIN + VINORELBINE | 100990484 |
| 10391149 | 10040762 | 1.66 | 72 | Palliative (P) | 2008-11-05 | 2017-11-03 | CTD Attenuated (Thalidomide 50mg) | 02 | N | DARATUMUMAB | 100594505 |
| 10391233 | 10040763 | 1.6 | 62 | Adjuvant (A) | 2019-10-24 | 2019-10-25 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101481083 |
| 10391242 | 10040764 | 1.7 | 63.7 | Curative (C) | 2019-02-07 | 2019-02-26 | MITOMYCIN | 02 | N | DABRAFENIB + TRAMETINIB | 101475669 |
| 10391310 | 10040765 | 1.7 | 102.9 | Adjuvant (A) | 2020-11-18 | 2020-12-13 | Busulfan Oral | 02 | N | CAPECITABINE + GEMCITABINE | 100619124 |
| 10391351 | 10040767 | null | 50.1 | 03 | 2021-08-15 | 2021-08-15 | Palbociclib | 02 | N | PALBOCICLIB | 101833101 |
| 10391389 | 10040768 | 1.7 | null | Palliative (P) | 2018-05-03 | 2018-05-04 | FEC + DOCETAXEL | 02 | N | MITOMYCIN | 101522551 |
| 10391416 | 10040769 | 1.73 | 79.3 | null | 2016-06-18 | 2016-06-18 | CISPLATIN + FLUOROURACIL | 02 | null | CVP R | 100096129 |
| 10391458 | 10040773 | null | null | Palliative (P) | 2018-05-27 | 2018-05-27 | EOX | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101610445 |
| 10391574 | 10040775 | null | null | 03 | 2020-09-29 | 2020-10-01 | BCG Intravesical | N | N | CYTARABINE | 100003974 |
| 10391595 | 10040778 | null | null | Curative (C) | null | 2020-01-01 | Cisplatin + Vinorelbine (IV) | 02 | N | BCG | 101048076 |
| 10391631 | 10040780 | 1.41 | 70.1 | Adjuvant (A) | 2019-11-05 | 2019-11-19 | Trial Unspecified | 02 | N | MITOMYCIN | 101153552 |
| 10391683 | 10040781 | null | 52.3 | Palliative (P) | 2019-11-15 | 2019-12-01 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | DABRAFENIB + TRAMETINIB | 100472483 |
| 10391784 | 10040787 | 1.68 | 63 | Palliative (P) | 2020-05-26 | 2020-06-10 | CHOP R - 21 days | 02 | N | CHOP R | 100995757 |
| 10391787 | 10040788 | 0 | null | 03 | 2018-07-21 | 2018-07-21 | CVP R | 02 | N | CYTARABINE | 100899946 |
| 10391840 | 10040791 | null | null | null | 2022-02-16 | 2022-02-19 | CHOP R - 21 days | 02 | null | CHOP R | 101858657 |
| 10391931 | 10040792 | 1.8 | 89 | 03 | 2019-02-24 | 2019-03-01 | Palbociclib | 02 | N | PALBOCICLIB | 100976667 |
| 10391935 | 10040793 | 1.62 | 70.6 | Palliative (P) | 2019-08-01 | 2019-08-16 | DABRAFENIB + TRAMETINIB | 02 | N | DARATUMUMAB | 101454987 |
| 10391941 | 10040794 | 1.73 | 77.1 | Palliative (P) | 2020-04-23 | 2020-05-02 | Cladribine (subcut) 5 days | N | N | TRIAL | 101608958 |
| 10391957 | 10040795 | 1.61 | 85 | Adjuvant (A) | 2018-12-07 | 2018-12-15 | Avelumab | 02 | N | AVELUMAB | 100414287 |
| 10391989 | 10040796 | 1.67 | 66.2 | Palliative (P) | 2018-10-07 | 2018-10-24 | R GCVP | 02 | N | POMALIDOMIDE | 101435946 |
| 10392100 | 10040798 | null | 0 | Curative (C) | 2019-03-30 | 2019-03-30 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100692543 |
| 10392325 | 10040803 | 1.68 | 103 | null | 2022-03-01 | 2022-03-15 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100748911 |
| 10392347 | 10040804 | 1.52 | 92.5 | Adjuvant (A) | 2016-06-28 | 2016-07-11 | BORTEZOMIB + THALIDOMIDE | N | N | BORTEZOMIB + THALIDOMIDE | 101734816 |
| 10392471 | 10040806 | 1.56 | 64 | null | 2016-11-27 | 2016-12-14 | FLUOROURACIL | 02 | null | FLUOROURACIL | 101015076 |
| 10392561 | 10040807 | 1.67 | 75.7 | Palliative (P) | 2019-08-19 | 2019-08-19 | FEC + DOCETAXEL | null | N | CISPLATIN + FLUOROURACIL | 100524794 |
| 10392643 | 10040809 | 1.62 | 91.1 | Curative (C) | 2015-10-16 | 2015-10-16 | Sunitinib | 02 | null | VENETOCLAX | 100843714 |
| 10392648 | 10040811 | 1.85 | 82 | Palliative (P) | 2019-09-21 | 2019-09-27 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | N | PAZOPANIB | 100363288 |
| 10392675 | 10040812 | 1.87 | 95 | Palliative (P) | 2019-06-17 | 2019-06-18 | CHOP R | 02 | N | CHOP R | 101724571 |
| 10392729 | 10040813 | 1.53 | 64.8 | Palliative (P) | 2018-09-29 | 2018-10-16 | POMALIDOMIDE | 02 | null | CISPLATIN + VINORELBINE | 100025261 |
| 10392747 | 10040814 | 1.76 | 47.6 | Palliative (P) | 2018-12-11 | 2019-08-19 | null | Y | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100733102 |
| 10392755 | 10040815 | null | null | Curative (C) | 2017-03-05 | 2017-03-05 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101538352 |
| 10392926 | 10040817 | null | 79 | Palliative (P) | 2020-04-10 | 2020-04-18 | Bortezomib +/- Dexamethasone | N | N | BORTEZOMIB | 100659922 |
| 10392961 | 10040819 | 1.67 | 69.8 | Palliative (P) | 2018-07-23 | 2019-06-26 | Gemcitabine + Capecitabine | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101666642 |
| 10392963 | 10040820 | 1.73 | 89 | null | 2019-03-30 | 2019-03-30 | Venetoclax | 2 | null | CISPLATIN + FLUOROURACIL | 101074116 |
| 10392982 | 10040821 | 1.65 | 83.6 | Palliative (P) | 2018-12-25 | 2018-12-25 | Folfirinox/ Folfoxiri | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100961874 |
| 10392983 | 10040822 | 1.55 | 65 | 03 | 2019-06-09 | 2020-04-08 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101777674 |
| 10393155 | 10040823 | 1.55 | 85 | Palliative (P) | 2019-08-02 | 2019-08-07 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + CISPLATIN | 100913566 |
| 10393347 | 10040826 | 1.67 | 0 | Adjuvant (A) | 2017-10-25 | 2017-10-25 | FEC + DOCETAXEL | N | N | POMALIDOMIDE | 100725246 |
| 10393501 | 10040827 | 1.64 | 57.2 | Palliative (P) | 2018-06-19 | 2018-06-19 | FLUOROURACIL | 02 | N | FLUOROURACIL | 101860313 |
| 10393536 | 10040828 | 1.56 | 49.6 | 03 | 2018-01-04 | 2018-01-04 | Carboplatin + Pembrolizumab + Pemetrexed | 01 | N | CYTARABINE | 101386614 |
| 10393632 | 10040830 | 1.56 | 71.8 | Palliative (P) | 2020-12-15 | 2020-12-20 | Trial Unspecified | 02 | N | TRIAL | 100930069 |
| 10393681 | 10040832 | null | 0 | Disease modification (D) | null | 2020-05-03 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | N | SUNITINIB | 100237756 |
| 10393729 | 10040833 | 1.64 | 65.5 | Neo-adjuvant (N) | 2017-11-21 | 2017-11-21 | CVP R | 02 | N | VENETOCLAX | 101140195 |